Influenza antiviral agents (M2 inhibitors and neuraminidase inhibitors) are widely licensed in the Community, but their use is not widespread.
Antivirale middelen tegen influenza (M2-remmers en neuraminidaseremmers) zijn in veel lidstaten geregistreerd, maar worden weinig gebruikt.